Maciej Wysocki
CEO

BioCam develops medical monitoring solutions that enhance patient comfort by facilitating real-time communication between patients and healthcare providers. The technology reduces anxiety during medical procedures by providing clear, actionable insights into patient status.
Raised to date
$480.7KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

CEO
Traditional capsule endoscopy requires patients to visit medical facilities, potentially causing anxiety and discomfort. Existing methods may also lack real-time monitoring and immediate alerts for medical personnel in case of abnormalities.
BioCam offers a patient-friendly, remote capsule endoscopy solution that enables real-time monitoring of the entire gastrointestinal tract. The system includes an ingestible endoscopic capsule, AI-powered telemedicine platform, and a mobile application. The capsule transmits images of the digestive system, while the AI software automatically detects and marks potential lesions, alerting medical staff to abnormalities in real-time. The mobile app provides patients with necessary information for exam preparation, enhancing convenience and reducing the need for in-person visits.
The primary target audience includes healthcare providers seeking remote diagnostic solutions and patients who require non-invasive gastrointestinal examinations.